|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
Laboratory Report
|
|
|
|||||||||||||||||||||||||
Hematology
| Test | 22-AUG-2024 | Reference Range | Unit |
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 4.4 | 4.0 - 11.0 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 3.9 L | 4.0 - 5.2 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 14.2 | 12 - 16 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 47.3 H | 36 - 46 | % |
| MCV [Entitic mean volume] in Red Blood Cells by Automated count | 87.7 | 80 - 100 | fL |
| MCH [Entitic mass] by Automated count | 28.6 | 27 - 33 | pg |
| MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count | 31.7 L | 32.0 - 36.0 | g/dL |
| Erythrocyte [DistWidth] in Blood by Automated count | 12.4 | 11.5 - 14.5 | % |
| Platelets [#/volume] in Blood by Automated count | 333.9 | 150 - 450 | 10*3/uL |
Chemistry
| Test | 22-AUG-2024 | Reference Range | Unit |
|---|---|---|---|
| Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 1275.9 H | 0 - 450 | pg/mL |
| Glucose [Mass/volume] in Serum or Plasma | 66.0 L | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 17.1 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 0.5 | 0.5 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 8.9 | 8.6 - 10.3 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 139.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 3.9 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 105.8 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 21.2 L | 22 - 29 | mmol/L |
| Protein [Mass/volume] in Serum or Plasma | 7.3 | 6.6 - 8.3 | g/dL |
| Albumin [Mass/volume] in Serum or Plasma | 4.2 | 3.5 - 5.2 | g/dL |
| Bilirubin.total [Mass/volume] in Serum or Plasma | 1.1 | 0.1 - 1.2 | mg/dL |
| Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 89.8 | 32 - 92 | U/L |
| Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 2.9 L | 7 - 56 | U/L |
| Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 12.5 | 10 - 40 | U/L |
| Magnesium [Mass/volume] in Serum or Plasma | 1.9 | 1.7 - 2.3 | mg/dL |
| Cholesterol [Mass/volume] in Serum or Plasma | 159.3 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 112.7 | 0 - 149 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 92.0 | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44.8 | 40 - 90 | mg/dL |
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | 4.8 - 5.9 | % |
| Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method | 0.0 | 0.0 - 19.9 | pg/mL |
| Ferritin [Mass/volume] in Serum or Plasma | 100.8 | 13 - 150 | ug/L |
| Iron [Mass/volume] in Serum or Plasma | 47.4 L | 50 - 170 | ug/dL |
| Iron binding capacity [Mass/volume] in Serum or Plasma | 403.7 | 250 - 450 | ug/dL |
| Iron saturation [Mass Fraction] in Serum or Plasma | 44.5 | 15 - 50 | % |
Annotation
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows markedly elevated NT-proBNP, suggestive of possible heart failure or cardiac strain. Mild normocytic anemia is present (low RBC, low MCHC, low iron), with normal ferritin and iron saturation. Glucose is slightly low; renal and liver function are within normal limits except for low ALT. Mildly low total CO₂ may indicate mild metabolic acidosis. No acute myocardial injury (normal troponin). Recommend clinical correlation for cardiac status and further evaluation of anemia and low glucose. |